Author | Veronica Hackethal MD


Tracking the Source of "Shotgun" ANA Testing

December 05, 2013

The ACR says that ANA subserology testing in conditions such as rheumatoid arthritis is rarely justified. Many rheumatologists are not acting accordingly. Why not?

Biologic Bloodhounds Tracking the Paths in RA Pathology

November 13, 2013

Two new strategies for breaking through the tangle of pathways to identify those most important to rheumatoid arthritis treatment converge on a shared goal: personalized medicine.

A DMARD by Any Other Name: New Classifications Proposed

October 18, 2013

Acronym alert: European rheumatologists are proposing new subtypes of disease-modifying antirheumatic drugs, prompted by advances in methods of drug development.

Treating Early Rheumatoid Arthritis: A Guideline Comparison

October 03, 2013

Recent English-language guidelines agree that rheumatoid arthritis (RA) needs to prompt treatment. But the definition of "early RA," and the regimens, differ considerably.